12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers
- Galecto (NASDAQ:GLTO) stock increased by 40.3% to $0.81 during Tuesday's after-market session. At the close, Galecto's trading volume reached 3.6 million shares. This is 790.3% of its average volume over the last 100 days. The company's market cap stands at $21.8 million.
- Exagen (NASDAQ:XGN) stock increased by 15.76% to $2.79. The market value of their outstanding shares is at $47.0 million.
- MSP Recovery (NASDAQ:LIFW) stock moved upwards by 13.87% to $0.17. MSP Recovery's trading volume hit 5.6 million shares by close, accounting for 18.3% of its average volume over the last 100 days. The company's market cap stands at $57.3 million.
- Brainstorm Cell (NASDAQ:BCLI) stock rose 10.96% to $0.43. At the close, Brainstorm Cell's trading volume reached 325.2K shares. This is 97.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $19.5 million.
- VYNE Therapeutics (NASDAQ:VYNE) stock increased by 9.62% to $3.76. The market value of their outstanding shares is at $12.3 million.
- Freeline Therapeutics (NASDAQ:FRLN) stock increased by 9.24% to $4.16. The company's market cap stands at $18.1 million.
Losers
- Minerva Surgical (NASDAQ:UTRS) shares decreased by 23.5% to $0.22 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 1.5 million shares, which is 465.5 percent of its average volume over the last 100 days. The company's market cap stands at $38.3 million.
- Femasys (NASDAQ:FEMY) stock fell 16.22% to $1.24. Femasys's trading volume hit 29.0 million shares by close, accounting for 761.5% of its average volume over the last 100 days. The company's market cap stands at $18.6 million.
- DMK Pharmaceuticals (NASDAQ:DMK) stock decreased by 15.25% to $0.65. Today's trading volume for this security ended up closing at 1.4 million shares, which is 890.0 percent of its average volume over the last 100 days. The company's market cap stands at $6.0 million.
- Adial Pharmaceuticals (NASDAQ:ADIL) shares declined by 11.58% to $2.75. The market value of their outstanding shares is at $3.3 million.
- Tharimmune (NASDAQ:THAR) shares declined by 11.19% to $0.26. Trading volume for this security closed at 13.2 million, accounting for 3742.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.5 million.
- SeqLL (NASDAQ:SQL) shares decreased by 10.41% to $16.53. The company's market cap stands at $6.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.